The multiple faces of RAGE – opportunities for therapeutic intervention in aging and chronic disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Expert opinion on therapeutic targets

• Publication date

  2016-04-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/14728222.2016.1111873PMID 26558318PMCID PMC4941230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction

  2015cited by this paper
• RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells

  2015influential reference
• Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice.

  2015cited by this paper
• Deletion of Receptor for Advanced Glycation End Products Exacerbates Lymphoproliferative Syndrome and Lupus Nephritis in B6-MRL Fas lpr/j Mice

  2015cited by this paper
• Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway

  2015cited by this paper
• Isolevuglandin-Type Lipid Aldehydes Induce the Inflammatory Response of Macrophages by Modifying Phosphatidylethanolamines and Activating the Receptor for Advanced Glycation Endproducts

  2015cited by this paper
• RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.

  2015cited by this paper
• Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?

  2015cited by this paper
• Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis

  2015cited by this paper
• S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand/RAGE axis in tumor progression?

  2015cited by this paper
• S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.

  2015cited by this paper
• Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.

  2015cited by this paper
• Diabetic retinopathy - ocular complications of diabetes mellitus.

  2015cited by this paper
• Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma

  2015cited by this paper
• Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer’s disease

  2015influential reference
• Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma

  2015cited by this paper
• Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma

  2015cited by this paper
• Role of receptor for advanced glycation end products in the complication and progression of various types of cancers.

  2015cited by this paper
• Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice

  2015cited by this paper
• Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure.

  2015cited by this paper
• Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease

  2014cited by this paper
• N&egr;-(Carboxymethyl)lysine-Receptor for Advanced Glycation End Product Axis Is a Key Modulator of Obesity-Induced Dysregulation of Adipokine Expression and Insulin Resistance

  2014cited by this paper
• The role of S100B in the interaction between adipocytes and macrophages

  2014cited by this paper
• Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes

  2014cited by this paper
• RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice

  2014cited by this paper
• Contribution of receptor for advanced glycation end products to vasculature-protecting effects of exercise training in aged rats.

  2014cited by this paper
• Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

  2014cited by this paper
• Therapeutic targets for rheumatoid arthritis: Progress and promises

  2014cited by this paper
• Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

  2014influential reference
• Unlocking the biology of RAGE in diabetic microvascular complications.

  2014cited by this paper
• BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

  2014cited by this paper
• S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells

  2014cited by this paper
• RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma.

  2014cited by this paper
• Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway

  2014cited by this paper
• Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis.

  2014cited by this paper
• Determinants of concentrations of N(ε)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancer.

  2014cited by this paper
• Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

  2014cited by this paper
• Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?

  2014cited by this paper
• Randomized Pilot Trial of Bariatric Surgery Versus Intensive Medical Weight Management on Diabetes Remission in Type 2 Diabetic Patients Who Do NOT Meet NIH Criteria for Surgery and the Role of Soluble RAGE as a Novel Biomarker of Success

  2014cited by this paper
• Formins as effector proteins of Rho GTPases

  2014cited by this paper
• Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.

  2013cited by this paper
• Combinatorial Library of Improved Peptide Aptamers, CLIPs to Inhibit RAGE Signal Transduction in Mammalian Cells

  2013cited by this paper
• Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond

  2013cited by this paper
• S100B Promotes Glioma Growth through Chemoattraction of Myeloid-Derived Macrophages

  2013cited by this paper
• Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE−/− mice by downregulating the HMGB1-RAGE axis

  2013cited by this paper
• RAGE Deficiency Improves Postinjury Sciatic Nerve Regeneration in Type 1 Diabetic Mice

  2013cited by this paper
• RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition

  2013cited by this paper
• RAGE in tissue homeostasis, repair and regeneration.

  2013cited by this paper
• Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.

  2013cited by this paper
• DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells.

  2013cited by this paper
• Opposing roles of RAGE and Myd88 signaling in extensive liver resection

  2012cited by this paper
• Receptor for Advanced Glycation End Products (RAGE) and Implications for the Pathophysiology of Heart Failure

  2012cited by this paper
• Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling

  2012cited by this paper
• Targeting receptor for advanced glycation end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth.

  2012cited by this paper
• S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.

  2012cited by this paper
• Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation

  2012cited by this paper
• Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction Pathways

  2012cited by this paper
• Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice

  2012cited by this paper
• Signal transduction in receptor for advanced glycation end products (RAGE). SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1.

  2012cited by this paper
• AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation.

  2012cited by this paper
• Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?

  2012cited by this paper
• The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.

  2012cited by this paper
• A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

  2012cited by this paper
• High‐mobility group box 1 activates caspase‐1 and promotes hepatocellular carcinoma invasiveness and metastases

  2012cited by this paper
• S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE)

  2011cited by this paper
• ROLE OF A-RECEPTOR FOR ADVANCED GLYCATION NDPRODUCTS INTERACTION IN OXIDATIVE STRESS AND YTOSOLIC PHOSPHOLIPASE A 2 ACTIVATION IN ASTROCYTES AND CEREBRAL ENDOTHELIAL CELLS

  2011cited by this paper
• Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.

  2011cited by this paper
• Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes

  2011cited by this paper
• Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice

  2011cited by this paper
• Signal Transduction in Receptor for Advanced Glycation End Products (RAGE)

  2011cited by this paper
• Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects

  2011cited by this paper
• S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release*

  2011influential reference
• Advanced glycation end product recognition by the receptor for AGEs.

  2011cited by this paper
• High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.

  2011cited by this paper
• Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells

  2011cited by this paper
• The 1.5 Å Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding*

  2010cited by this paper
• Aldose Reductase and AGE–RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging rats

  2010cited by this paper
• Activation of the ROCK1 Branch of the Transforming Growth Factor-&bgr; Pathway Contributes to RAGE-Dependent Acceleration of Atherosclerosis in Diabetic ApoE-Null Mice

  2010cited by this paper
• RAGE Modulates Hypoxia/Reoxygenation Injury in Adult Murine Cardiomyocytes via JNK and GSK-3β Signaling Pathways

  2010cited by this paper
• The Role of the Receptor for Advanced Glycation End-Products in a Murine Model of Silicosis

  2010cited by this paper
• Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE)

  2010cited by this paper
• RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

  2010cited by this paper
• Structural basis for ligand recognition and activation of RAGE.

  2010cited by this paper
• Formins in cell signaling.

  2010cited by this paper
• Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse

  2010cited by this paper
• Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic Macrophages*

  2010cited by this paper
• Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.

  2010cited by this paper
• Role of NADPH oxidase in retinal microvascular permeability increase by RAGE activation.

  2009cited by this paper
• Atherosclerosis in autoimmune diseases

  2009cited by this paper
• Soluble forms of RAGE in internal medicine

  2009cited by this paper
• Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases.

  2009cited by this paper
• RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer's disease animal model

  2009cited by this paper
• Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.

  2009cited by this paper
• Association between the RAGE G82S polymorphism and Alzheimer’s disease

  2009cited by this paper
• AGE and their receptor RAGE in systemic autoimmune diseases: An inflammation propagating factor contributing to accelerated atherosclerosis

  2009cited by this paper
• A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice.

  2008influential reference
• Role of advanced glycation end products in diabetic neuropathy.

  2008cited by this paper
• Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

  2008cited by this paper
• Oxygen Deprivation Triggers Upregulation of Early Growth Response-1 by the Receptor for Advanced Glycation End Products

  2008cited by this paper
• RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation1

  2008cited by this paper

• The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias

  2025cites this paper
• A receptor for glycation end products (RAGE) is a key transmitter between garb-aging and inflammaging.

  2025cites this paper
• Genetic Variation in the Receptor for Advanced Glycation End Product (1704G > T) and Matrix Metalloproteinase-9 (-1562 C/T) in Type 2 Diabetic Patients with Nephropathy in Western Rajasthan

  2025cites this paper
• AGE-RAGE Pathway as a Potential Therapeutic Target

  2025cites this paper
• Changes in Gene Expression Patterns in Young and Senescent Fibroblasts in Glycated Three-Dimensional Collagen Matrices

  2025cites this paper
• Development of New Benzo[b]Thiophene‐2‐Carboxamide Derivatives as Advanced Glycation End‐Products Receptor (RAGE) Antagonists

  2025cites this paper
• Glycative stress as a cause of macular degeneration.

  2024cites this paper
• Assessment of cardiac and skeletal muscle metabolites using 1H‐MRS and chemical‐shift encoded magnetic resonance imaging: Impact of diabetes, RAGE, and DIAPH1

  2024cites this paper
• Upregulation of EFCAB7 after radiofrequency ablation promoting hepatocellular carcinoma metastasis and survival by regulating PARK7

  2024cites this paper
• In vivo glycation-interplay between oxidant and carbonyl stress in bone.

  2024cites this paper
• Bioinformatics reveals the pathophysiological relationship between diabetic nephropathy and periodontitis in the context of aging

  2024cites this paper
• An evaluation of the role of miR-361-5p in senescence and systemic ageing.

  2023cites this paper
• Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study

  2023cites this paper
• Effects of acute aerobic exercise on circulating sTLR and sRAGE profiles in normal‐ and abnormal‐glucose‐tolerant individuals

  2023cites this paper
• Involvement of the Receptor for Advanced Glycation End Products (RAGE) in High Fat-High Sugar Diet-Induced Anhedonia in Rats.

  2023cites this paper
• Protein–Ligand CH−π Interactions: Structural Informatics, Energy Function Development, and Docking Implementation

  2023cites this paper
• Skeletal Senescence with Aging and Type 2 Diabetes

  2023cites this paper
• Immunology of chronic low-grade inflammation: relationship with metabolic function.

  2023cites this paper
• ЛОГІКА ВИЗНАЧЕННЯ ЗДОРОВ'Я ІНДИВІДА ТА ПОПУЛЯЦІЇ. ЧАСТИНА 2. ЕВОЛЮЦІЙНА МЕДИЦИНА. СИСТЕМНО-БІОЛОГІЧНІ ТА ІНФОРМАЦІЙНІ АСПЕКТИ ЗДОРОВ'Я ЛЮДИНИ

  2022cites this paper
• The potential link between Covid‐19 and multiple myeloma: A new saga

  2022cites this paper
• Research Advances on the Damage Mechanism of Skin Glycation and Related Inhibitors

  2022cites this paper
• Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective

  2022cites this paper
• The receptor for advanced glycation end products and its ligands’ expression in OVE26 diabetic sciatic nerve during the development of length‐dependent neuropathy

  2022cites this paper
• Effects of diabetes on osteocytes

  2022cites this paper
• SARS-CoV-2 Causes Lung Inflammation through Metabolic Reprogramming and RAGE

  2022cites this paper
• Intracellular Protein S-Nitrosylation—A Cells Response to Extracellular S100B and RAGE Receptor

  2022cites this paper
• RAGE and Serum Copeptin Act as a Potential Biomarker for Chronic Kidney Disease with and without Type 2 Diabetes Mellitus

  2022cites this paper
• Cellular senescence and the skeleton: pathophysiology and therapeutic implications

  2022cites this paper
• Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications

  2021cites this paper
• Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes.

  2021cites this paper
• Glycation End-Products and their Receptors: Pathophysiology and Therapeutic Targeting in Diabetes Mellitus

  2021cites this paper
• Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance

  2021cites this paper
• Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus

  2021cites this paper
• The cross‐talk between RAGE and DIAPH1 in neurological complications of diabetes: A review

  2021cites this paper
• Potential therapeutic applications of mesenchymal stem cells for erectile dysfunction in diabetes mellitus: From preclinical/clinical perspectives

  2021cites this paper
• Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients

  2021cites this paper
• Danger-associated molecular pattern molecules and the receptor for advanced glycation end products enhance ANCA-induced responses

  2021cites this paper
• Heme & RAGE: A new opportunistic relationship?

  2021cites this paper
• Long-term intake of the reactive metabolite methylglyoxal is not toxic in mice.

  2020cites this paper
• Harnessing Stem Cell Potential for the Treatment of Erectile Function with Diabetes Mellitus: From Preclinical/Clinical Perspectives to Penile Tissue Engineering.

  2020cites this paper
• Association of DIAPH1 gene polymorphisms with ischemic stroke

  2020influential citation
• The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding

  2020cites this paper
• Unravelling the role of Receptor for advanced glycation end products (RAGE) and its ligands in Myasthenia Gravis.

  2020cites this paper
• Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models

  2020cites this paper
• Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review

  2020cites this paper
• Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach

  2020cites this paper
• The potential role of dietary advanced glycation endproducts in the development of chronic non-infectious diseases: a narrative review

  2020cites this paper
• Receptor for advanced glycation end products modulates oxidative stress and mitochondrial function in the soleus muscle of mice fed a high-fat diet

  2020cites this paper
• Identification of key genes and pathways in syphilis combined with diabetes: a bioinformatics study

  2020cites this paper
• Pathogenesis of psoriasis in the “omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances

  2020cites this paper
• RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?

  2020cites this paper
• Metal-induced neurotoxicity in a RAGE-expressing C. elegans model.

  2020cites this paper
• Vascular Component of Neuroinflammation in Experimental Alzheimer’s Disease in Mice

  2020cites this paper
• RAGE and its ligands: from pathogenesis to therapeutics

  2020cites this paper
• RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin

  2020cites this paper
• Effects of the age/rage axis in the platelet activation.

  2020cites this paper
• Ca2+-Binding Proteins of the EF-Hand Superfamily: Diagnostic and Prognostic Biomarkers and Novel Therapeutic Targets.

  2019cites this paper
• RAGE Signaling in Skeletal Biology

  2019cites this paper
• Influence of the Maillard Reaction on the Allergenicity of Food Proteins and the Development of Allergic Inflammation

  2019cites this paper
• Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Extracellular S100A4 affects endothelial cell integrity and stimulates transmigratory behavior of human A375 melanoma cells

  2019cites this paper
• Gene doubling increases glyoxalase 1 expression in RAGE knockout mice.

  2019cites this paper
• СИСТЕМНА БІОЛОГІЯ СТАРІННЯ: МОДЕЛЮВАННЯ МОЛЕКУЛЯРНИХ МЕХАНІЗМІВ РОЗВИТКУ ВІКОВИХ ЗАХВОРЮВАНЬ. КОНЦЕПТУАЛЬНИЙ АНАЛІТИЧНИЙ ОГЛЯД

  2019cites this paper
• Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology

  2019cites this paper
• Analysis of Oxidative Stress-Related Markers in Crohn’s Disease Patients at Surgery and Correlations with Clinical Findings

  2019cites this paper
• Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation

  2019cites this paper
• S100 proteins in obesity: liaisons dangereuses

  2019cites this paper
• Oxidation and Inflammation in the Immune and Nervous Systems, a Link Between Aging and Anxiety

  2019cites this paper
• Biochemical Mechanisms of Vascular Complications in Diabetes

  2019cites this paper
• Serum Levels of Protein-Bound Methylglyoxal-Derived Hydroimidazolone-1 are Independently Correlated with Asymmetric Dimethylarginine

  2019cites this paper
• Soluble Forms of the Receptor for Advanced Glycation Endproducts (RAGE) in Periodontitis

  2019cites this paper
• Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of soluble RAGEs

  2019cites this paper
• Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice.

  2019influential citation
• The Trp Triad within the V-Domain of the Receptor for Advanced Glycation Endproducts (RAGE) Modulates Folding, Stability, and Ligand Binding

  2019cites this paper
• S100 proteins: Diagnostic and prognostic biomarkers in laboratory medicine.

  2019cites this paper
• The Receptor for Advanced Glycation End Products (RAGE) and DIAPH1: Implications for vascular and neuroinflammatory dysfunction in disorders of the central nervous system.

  2019cites this paper
• Dynamic oligomerization of hRAGE's transmembrane and cytoplasmic domains within SDS micelles.

  2019cites this paper
• Knockout of receptor for advanced glycation end‐products attenuates age‐related renal lesions

  2019cites this paper
• The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases

  2018cites this paper
• Oxidation and Inflammation in the Immune and Nervous Systems, a Link Between Aging and Anxiety

  2018cites this paper
• Diabetes and Advanced Glycation End Products

  2018cites this paper
• Mechanistic targeting of advanced glycation end-products in age-related diseases.

  2018influential citation
• RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy

  2018cites this paper
• In silico investigation of extracellular domain of RAGE receptor interaction with A-box and B-box of HMGB1 protein

  2018cites this paper
• A C. elegans Model for the Study of RAGE-Related Neurodegeneration

  2018cites this paper
• Immune neutralization of the receptor for advanced glycation end products reduce liver oxidative damage induced by an acute systemic injection of lipopolysaccharide

  2018cites this paper
• Glutathione is the main endogenous inhibitor of protein glycation.

  2017cites this paper
• The anti-inflammatory and anti-glycative effects of rosmarinic acid in the livers of type 1 diabetic mice

  2017cites this paper
• Genetics of aging and longevity

  2017cites this paper
• Expression and purification of the extracellular domains of human glycoprotein VI (GPVI) and the receptor for advanced glycation end products (RAGE) from Rattus norvegicus in Leishmania tarentolae

  2017cites this paper
• DAMPs, endogenous danger signals fueling airway inflammation in COPD

  2017cites this paper
• Intrinsic Mesenchymal Stem Cell Dysfunction in Diabetes Mellitus: Implications for Autologous Cell Therapy

  2017cites this paper
• Spinal Arteriolosclerosis Is Common in Older Adults and Associated With Parkinsonism

  2017cites this paper
• A model of chronic diabetic polyneuropathy: benefits from intranasal insulin are modified by sex and RAGE deletion.

  2017cites this paper
• A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE)

  2016cites this paper
• Extracellular S100A4 affects endothelial cell integrity and stimulates transmigration of A375 melanoma cells.

  2016cites this paper
• Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.

  2016cites this paper
• The role of oxidative and inflammatory stress and persistent viral infections in immunosenescence.

  2016cites this paper
• RAGE at Tumor Microenvironment. Looking at Tumor-associated Macrophages

  2015cites this paper